Warren, Chad M.
Halas, Monika
Goldspink, Paul H.
Feng, Han-Zhong
Herren, Anthony W.
Wolska, Beata M.
de Tombe, Pieter P.
Jin, Jian-Ping
Solaro, R. John http://orcid.org/0000-0002-4196-0353
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (RO1 HL 128468 MPI, RO1 HL 128468 MPI, PO1 HL062426 Project 1, PO1 HL062426 Project 3, PO1 HL062426 Core C, RO1 HL127691, RO1 HL127691, RO1 HL127691)
Article History
Received: 15 October 2021
Accepted: 10 March 2022
First Online: 22 March 2022
Declarations
:
: R. John Solaro is a member of the Scientific Advisory Board of Cytokinetics, Inc., a consultant to Pfizer, Inc., and a member of the Heart Failure Advisory Board of Amgen. The authors declare no additional competing financial interests.
: This article contains studies with animals and all animal protocols were approved by the animal care and use committee of the University of Illinois at Chicago, which also conforms to the “Guide for the Care and Use of Laboratory Animals” published by the United States National Institutes of Health, 8th edition, revised 2011.